Literature DB >> 8475033

Effects of microtubule inhibitors on protein synthesis in Plasmodium falciparum.

A Bell1, B Wernli, R M Franklin.   

Abstract

At low concentrations, both isomers of tubulozole (C, T) inhibit Plasmodium falciparum but only tubulozole C inhibits mammalian cells. Since tubulozole C prevents polymerization of mammalian tubulin whereas tubulozole T does not, the antimalarial action of tubulozoles may not involve microtubules. The present study concerns the inhibition of parasite protein synthesis by the tubulozoles. While tubulozoles took 3-4 h to kill parasites in erythrocytic culture, they inhibited protein synthesis within 10 min. The concentrations of the drug required were, however, too high for this to account for their antimalarial action. The microtubule inhibitor colcemid inhibited protein synthesis rapidly and at relevant concentrations, but vinblastine did not inhibit protein synthesis. Tubulozole T and colcemid inhibited protein synthesis posttranscriptionally since they had little effect on RNA synthesis. Analysis of labelled parasite proteins by two-dimensional gel electrophoresis showed that while it inhibited synthesis of most proteins to the same degree, tubulozole T super-inhibited the synthesis of certain proteins. This may cause its antimalarial effect at low concentrations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475033     DOI: 10.1007/bf00932261

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  21 in total

Review 1.  The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles.

Authors:  E Lacey
Journal:  Int J Parasitol       Date:  1988-11       Impact factor: 3.981

2.  Association of ribosomes with in vitro assembled microtubules.

Authors:  K A Suprenant; L B Tempero; L E Hammer
Journal:  Cell Motil Cytoskeleton       Date:  1989

3.  Compounds binding to cytoskeletal proteins are active against Plasmodium falciparum in vitro.

Authors:  A Dieckmann-Schuppert; R M Franklin
Journal:  Cell Biol Int Rep       Date:  1989-05

4.  Isolation of alpha-tubulin genes from the human malaria parasite, Plasmodium falciparum: sequence analysis of alpha-tubulin.

Authors:  S P Holloway; P F Sims; C J Delves; J G Scaife; J E Hyde
Journal:  Mol Microbiol       Date:  1989-11       Impact factor: 3.501

5.  Mode of action of tubulozoles against Plasmodium falciparum in vitro.

Authors:  A Dieckmann-Schuppert; R M Franklin
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

6.  Nucleotide sequence and expression of a beta-tubulin gene from Plasmodium falciparum, a malarial parasite of man.

Authors:  J G Wesseling; R Dirks; M A Smits; J G Schoenmakers
Journal:  Gene       Date:  1989-11-30       Impact factor: 3.688

7.  A procedure for the harvesting of mammalian plasmodia.

Authors:  A Zuckerman; D Spira; J Hamburger
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

8.  Synchronization of Plasmodium falciparum erythrocytic stages in culture.

Authors:  C Lambros; J P Vanderberg
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

9.  Plasmodium falciparum: assessment of in vitro growth by [3H]hypoxanthine incorporation.

Authors:  J D Chulay; J D Haynes; C L Diggs
Journal:  Exp Parasitol       Date:  1983-02       Impact factor: 2.011

10.  Examining the function and regulation of hsp 70 in cells subjected to metabolic stress.

Authors:  R P Beckmann; M Lovett; W J Welch
Journal:  J Cell Biol       Date:  1992-06       Impact factor: 10.539

View more
  2 in total

Review 1.  Cytoskeleton of apicomplexan parasites.

Authors:  Naomi S Morrissette; L David Sibley
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

2.  Cellular effects of curcumin on Plasmodium falciparum include disruption of microtubules.

Authors:  Rimi Chakrabarti; Parkash S Rawat; Brian M Cooke; Ross L Coppel; Swati Patankar
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.